Hongri Pharmaceutical disclosed in the third quarter report on October 29, 2021 that the number of shareholders of the company as of September 30, 2021 was 96,600, a decrease of 3,428 households or 3.43% compared with the previous period (June 30, 2021).
The number of shareholders of Hongri Pharmaceutical is higher than the industry average. According to Choice data, as of September 30, 2021, the average number of shareholders of listed companies in the pharmaceutical and biological industry was 40,900. Among them, the number of shareholders of the company is in the range of 15,000 to 30,000, accounting for the highest proportion, 30.15%.
Distribution of the number of shareholders in the pharmaceutical and biological industry
Number of shareholders and share price
Since December 31, 2020, the number of shareholders of the company has decreased significantly, with a decline of 11.12%. Share prices fell by 5.45% in the range from December 31, 2020 to September 30, 2021.
Number of shareholders and share price
Number of shareholders and share capital
As of September 30, 2021, the company's latest total share capital was 3.004 billion shares, of which the outstanding share capital was 2.682 billion shares. The average number of shares in circulation increased from 26,800 shares in the previous period to 27,800 shares, and the average market value of households was 119,100 yuan.
The amount of shareholding per household
The average market value of Hongri Pharmaceutical households is lower than the industry average. According to Choice data, as of September 30, 2021, the average household of A-share listed companies in the pharmaceutical and biological industry held a circulating stock market value of 396,200 yuan. Among them, 25.77% of the company's households hold the circulating stock market value in the range of 135,000 to 275,000.
The average circulating market value distribution of households in the pharmaceutical and biological industry
Shenzhen Stock Connect holds shares
As of September 30, 2021, the number of shares held by Shenzhen Stock Connect in Hongri Pharmaceutical was 17.9309 million shares, accounting for 0.59% of the outstanding share capital, down 7.22% from 19.3271 million shares in the previous period (June 30, 2021).
Shenzhen Stock Connect shareholding chart
Disclaimer: This article is based on big data production, for reference only, does not constitute any investment advice, and operates accordingly at your own risk.